10-Q Filing

ST JUDE MEDICAL INC CIK: 203077 Q3 2009

Filing Information

Form Type	10-Q
Accession Number	`0000897101-09-002245`
Period End Date	20090930
Filing Date	20091110
Fiscal Year	2009
Fiscal Period	Q3
XBRL Instance	stj-20091003.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 82 Income Statement 32 Cash Flow Statement 31

Balance Sheet 82 line items

Line Item	Tag	Value	Unit	Period
Allowance for Doubtful Accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$32.61M	USD	Point-in-time
Allowance for Doubtful Accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$28.97M	USD	Point-in-time
Preferred Stock, Par Value	`PreferredStockParOrStatedValuePerShare`	1.00	pure	Point-in-time
Preferred Stock, Par Value	`PreferredStockParOrStatedValuePerShare`	1.00	pure	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common Stock, Par Value	`CommonStockParOrStatedValuePerShare`	0.10	pure	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$136.44M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$798.28M	USD	Point-in-time
Common Stock, Par Value	`CommonStockParOrStatedValuePerShare`	0.10	pure	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $32,607 at October 3, 2009 and $28,971 at January 3, 2009	`AccountsReceivableNetCurrent`	$1.19B	USD	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $32,607 at October 3, 2009 and $28,971 at January 3, 2009	`AccountsReceivableNetCurrent`	$1.10B	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	336.60M	shares	Point-in-time
Inventories	`InventoryNet`	$681.73M	USD	Point-in-time
Inventories	`InventoryNet`	$546.50M	USD	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	345.33M	shares	Point-in-time
Deferred income taxes, net	`DeferredTaxAssetsNetCurrent`	$154.95M	USD	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	345.33M	shares	Point-in-time
Deferred income taxes, net	`DeferredTaxAssetsNetCurrent`	$137.04M	USD	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	336.60M	shares	Point-in-time
Other	`OtherAssetsCurrent`	$202.33M	USD	Point-in-time
Other	`OtherAssetsCurrent`	$158.82M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$2.08B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$3.03B	USD	Point-in-time
Property, plant and equipment, at cost	`PropertyPlantAndEquipmentGross`	$1.68B	USD	Point-in-time
Property, plant and equipment, at cost	`PropertyPlantAndEquipmentGross`	$1.93B	USD	Point-in-time
Less: accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$695.80M	USD	Point-in-time
Less: accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$807.95M	USD	Point-in-time
Net property, plant and equipment	`PropertyPlantAndEquipmentNet`	$1.12B	USD	Point-in-time
Net property, plant and equipment	`PropertyPlantAndEquipmentNet`	$980.18M	USD	Point-in-time
Goodwill	`Goodwill`	$2.02B	USD	Point-in-time
Goodwill	`Goodwill`	$1.98B	USD	Point-in-time
Other intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$472.05M	USD	Point-in-time
Other intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$493.54M	USD	Point-in-time
Other	`OtherAssetsNoncurrent`	$184.16M	USD	Point-in-time
Other	`OtherAssetsNoncurrent`	$229.57M	USD	Point-in-time
Total other assets	`TotalOtherAssets`	$2.66B	USD	Point-in-time
Total other assets	`TotalOtherAssets`	$2.72B	USD	Point-in-time
TOTAL ASSETS	`Assets`	$6.87B	USD	Point-in-time
TOTAL ASSETS	`Assets`	$5.72B	USD	Point-in-time
Current debt obligations	`DebtCurrent`	$339.60M	USD	Point-in-time
Current debt obligations	`DebtCurrent`	$75.52M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$238.31M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$177.97M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	-	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$17.61M	USD	Point-in-time
Employee compensation and related benefits	`EmployeeRelatedLiabilitiesCurrent`	$287.49M	USD	Point-in-time
Employee compensation and related benefits	`EmployeeRelatedLiabilitiesCurrent`	$297.29M	USD	Point-in-time
Other	`OtherLiabilitiesCurrent`	$428.50M	USD	Point-in-time
Other	`OtherLiabilitiesCurrent`	$399.80M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.03B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.23B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$1.63B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$1.13B	USD	Point-in-time
Deferred income taxes, net	`DeferredTaxLiabilitiesNoncurrent`	$112.23M	USD	Point-in-time
Deferred income taxes, net	`DeferredTaxLiabilitiesNoncurrent`	$136.05M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$279.59M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$219.76M	USD	Point-in-time
Total liabilities	`Liabilities`	$3.28B	USD	Point-in-time
Total liabilities	`Liabilities`	$2.49B	USD	Point-in-time
Preferred stock ($1.00 par value; 25,000,000 shares authorized; none outstanding)	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock ($1.00 par value; 25,000,000 shares authorized; none outstanding)	`PreferredStockValue`	-	USD	Point-in-time
Common stock ($0.10 par value; 500,000,000 shares authorized; 336,602,506 and 345,332,272 shares issued and outstanding at October 3, 2009 and January 3, 2009, respectively)	`CommonStockValue`	$33.66M	USD	Point-in-time
Common stock ($0.10 par value; 500,000,000 shares authorized; 336,602,506 and 345,332,272 shares issued and outstanding at October 3, 2009 and January 3, 2009, respectively)	`CommonStockValue`	$34.53M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$219.04M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$19.88M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$2.98B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$3.42B	USD	Point-in-time
Cumulative translation adjustment	`AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax`	$-1.02M	USD	Point-in-time
Cumulative translation adjustment	`AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax`	$104.52M	USD	Point-in-time
Unrealized gain on available-for-sale securities	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$8.85M	USD	Point-in-time
Unrealized gain on available-for-sale securities	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$6.14M	USD	Point-in-time
Unrealized loss on derivative financial instruments	`AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax`	$-411.00K	USD	Point-in-time
Unrealized loss on derivative financial instruments	`AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax`	-	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$3.59B	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$3.24B	USD	Point-in-time
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$5.72B	USD	Point-in-time
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$6.87B	USD	Point-in-time

Income Statement 32 line items

Line Item	Tag	Value	Unit	Period
Net sales	`SalesRevenueNet`	$3.48B	USD	3 Qtrs
Net sales	`SalesRevenueNet`	$1.16B	USD	1 Quarter
Cost of sales before special charges	`CostOfSalesBeforeSpecialCharges`	$899.71M	USD	3 Qtrs
Cost of sales before special charges	`CostOfSalesBeforeSpecialCharges`	$299.67M	USD	1 Quarter
Special charges	`SpecialCharges`	$6.06M	USD	1 Quarter
Special charges	`SpecialCharges`	$6.06M	USD	3 Qtrs
Gross profit	`GrossProfit`	$2.57B	USD	3 Qtrs
Gross profit	`GrossProfit`	$853.88M	USD	1 Quarter
Selling, general and administrative expense	`SellingGeneralAndAdministrativeExpense`	$1.28B	USD	3 Qtrs
Selling, general and administrative expense	`SellingGeneralAndAdministrativeExpense`	$427.23M	USD	1 Quarter
Research and development expense	`ResearchAndDevelopmentExpense`	$142.22M	USD	1 Quarter
Research and development expense	`ResearchAndDevelopmentExpense`	$424.63M	USD	3 Qtrs
Special charges	`RestructuringSettlementAndImpairmentProvisions`	$42.39M	USD	1 Quarter
Special charges	`RestructuringSettlementAndImpairmentProvisions`	$42.39M	USD	3 Qtrs
Operating profit	`OperatingIncomeLoss`	$828.95M	USD	3 Qtrs
Operating profit	`OperatingIncomeLoss`	$242.03M	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-35.87M	USD	3 Qtrs
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-23.59M	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$793.08M	USD	3 Qtrs
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$218.44M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$205.51M	USD	3 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$51.50M	USD	1 Quarter
Net earnings	`NetIncomeLoss`	$166.94M	USD	1 Quarter
Net earnings	`NetIncomeLoss`	$587.58M	USD	3 Qtrs
Basic	`EarningsPerShareBasic`	$0.49	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$1.71	USD	3 Qtrs
Diluted	`EarningsPerShareDiluted`	$1.69	USD	3 Qtrs
Diluted	`EarningsPerShareDiluted`	$0.48	USD	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	340.65M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	344.42M	shares	3 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	344.30M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	348.24M	shares	3 Qtrs

Cash Flow Statement 31 line items

Line Item	Tag	Value	Unit	Period
Net earnings	`NetIncomeLoss`	$587.58M	USD	3 Qtrs
Net earnings	`NetIncomeLoss`	$166.94M	USD	1 Quarter
Depreciation	`Depreciation`	$111.81M	USD	3 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$44.83M	USD	3 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$158.00K	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$44.13M	USD	3 Qtrs
Excess tax benefits from stock-based compensation	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	$19.13M	USD	3 Qtrs
Investment impairment charges	`ImpairmentOfInvestments`	$8.30M	USD	3 Qtrs
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$-1.11M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$53.95M	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$118.27M	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherOperatingAssets`	$22.68M	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-35.40M	USD	3 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$4.88M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$553.38M	USD	3 Qtrs
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$236.33M	USD	3 Qtrs
Business acquisition payments, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$14.79M	USD	3 Qtrs
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$15.35M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-266.47M	USD	3 Qtrs
Proceeds from exercise of stock options and stock issued	`ProceedsFromStockOptionsExercised`	$87.39M	USD	3 Qtrs
Excess tax benefits from stock-based compensation	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$19.13M	USD	3 Qtrs
Common stock repurchased, including related costs	`PaymentsForRepurchaseOfCommonStock`	$500.00M	USD	3 Qtrs
Proceeds from borrowings under debt facilities	`ProceedsFromIssuanceOfLongTermDebt`	$9.80B	USD	3 Qtrs
Principal payments on debt facilities	`RepaymentsOfLongTermDebt`	$9.04B	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$366.50M	USD	3 Qtrs
Effect of currency exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$8.43M	USD	3 Qtrs
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$661.84M	USD	3 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$798.28M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$136.44M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$798.28M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$136.44M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.